BI 3031185
BI 3031185 is a pharmaceutical drug with 4 clinical trials. Currently 2 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 2 completed trials
Phase Distribution
Phase Distribution
4
Early Stage
0
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 1Trial Status & Enrollment
100.0%
2 of 2 finished
0.0%
0 ended early
2
trials recruiting
4
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A Study to Test How BI 3031185 is Tolerated by People With Borderline Personality Disorder or Attention-deficit/Hyperactivity Disorder
A Study to Test How Well Different Doses of BI 3031185 Are Tolerated by Healthy Men
A Study in Healthy People to Test How Itraconazole Influences the Amount of BI 3031185 in the Blood
A Study in Healthy Men to Test How Different Doses of BI 3031185 Are Tolerated and How Food Influences the Amount of BI 3031185 in the Blood
Clinical Trials (4)
A Study to Test How BI 3031185 is Tolerated by People With Borderline Personality Disorder or Attention-deficit/Hyperactivity Disorder
A Study to Test How Well Different Doses of BI 3031185 Are Tolerated by Healthy Men
A Study in Healthy People to Test How Itraconazole Influences the Amount of BI 3031185 in the Blood
A Study in Healthy Men to Test How Different Doses of BI 3031185 Are Tolerated and How Food Influences the Amount of BI 3031185 in the Blood
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4